Zenas BioPharma, Inc. - ZBIO

SEC FilingsOur ZBIO Tweets

About Gravity Analytica

Recent News

  • 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.03.2025 - Cantor Global Healthcare Conference 2025
  • 09.03.2025 - Cantor Global Healthcare Conference 2025
  • 09.02.2025 - Citi's 2025 Biopharma Back to School Conference
  • 09.02.2025 - Citi's 2025 Biopharma Back to School Conference
  • 09.02.2025 - Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
  • 09.02.2025 - Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
  • 08.26.2025 - Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
  • 08.26.2025 - Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Recent Filings

  • 08.12.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.12.2025 - 8-K Current report
  • 08.12.2025 - EX-99.1 EX-99.1
  • 08.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors